# A Healthy Female and Male Volunteers Aspirin Study

> **NCT01448031** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Capsule ASA 81mg/esomeprazole 20mg
- **DRUG:** Acetylsalicylzuur Apotex Cardio

## Key facts

- **NCT ID:** NCT01448031
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2012-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448031, "A Healthy Female and Male Volunteers Aspirin Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01448031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*